Blockade of chemokine signaling in patients with multiple sclerosis.
Zipp F, Hartung HP, Hillert J, Schimrigk S, Trebst C, Stangel M, Infante-Duarte C, Jakobs P, Wolf C, Sandbrink R, Pohl C, Filippi M; CCR1 Antagonist Study Group.
Zipp F, et al.
Neurology. 2006 Nov 28;67(10):1880-3. doi: 10.1212/01.wnl.0000244420.68037.86.
Neurology. 2006.
PMID: 17130431
Clinical Trial.